Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
| 05/31/2016 | 05/31/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 4.61M | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 4.61M | |||
| Cost of Revenue | -- | 3.65M | |||
| Gross Profit | -- | 958.90K | |||
| SG&A Expenses | -- | 1.49M | |||
| Depreciation & Amortization | -- | 20.00K | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -- | 5.20M | |||
| Operating Income | -- | -592.60K | |||
| Income Before Tax | -- | -1.75M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -- | -1.75 | |||
| Earnings from Discontinued Operations | -- | 0.00 | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -- | -1.75M | |||
| EBIT | -- | -592.60K | |||
| EBITDA | -- | -572.60K | |||
| EPS Basic | -- | -0.01 | |||
| Normalized Basic EPS | -- | -0.01 | |||
| EPS Diluted | -- | -0.01 | |||
| Normalized Diluted EPS | -- | -0.01 | |||
| Average Basic Shares Outstanding | -- | 684.83M | |||
| Average Diluted Shares Outstanding | -- | 684.83M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||